share_log

山东新华制药股份(00719.HK):取得布洛芬缓释胶囊药品注册证书

Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK): Obtained ibuprofen sustained-release capsule drug registration certificate

Gelonghui Finance ·  Mar 12 04:42

Gelonghui March 12丨Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) issued an announcement. Recently, Xinhua Pharmaceutical received the “Drug Registration Certificate” for ibuprofen sustained-release capsules approved and issued by the State Drug Administration. Xinhua Pharmaceutical's ibuprofen sustained-release capsules obtained a drug registration certificate in March 2024, further enriching the company's ibuprofen product line and providing patients with new antipyretic and analgesic medication options.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment